Growth Metrics

Organon (OGN) Liabilities and Shareholders Equity (2020 - 2026)

Organon has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $13.0 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity fell 1.22% year-over-year to $13.0 billion; the TTM value through Mar 2026 reached $52.9 billion, up 3.42%, while the annual FY2025 figure was $12.9 billion, 1.79% down from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $13.0 billion at Organon, up from $12.9 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $13.6 billion in Q3 2025 and troughed at $10.4 billion in Q3 2022.
  • A 5-year average of $12.0 billion and a median of $12.1 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 7.92% in 2022 and later increased 15.8% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $11.0 billion in 2022, then increased by 10.07% to $12.1 billion in 2023, then rose by 8.65% to $13.1 billion in 2024, then fell by 1.79% to $12.9 billion in 2025, then grew by 1.0% to $13.0 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for OGN at $13.0 billion in Q1 2026, $12.9 billion in Q4 2025, and $13.6 billion in Q3 2025.